Literature DB >> 2778080

Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.

J M Swenson1, B C Hill, C Thornsberry.   

Abstract

A total of 53 strains of enterococci, including recently isolated strains with high-level resistance to vancomycin, were tested for vancomycin susceptibility by broth microdilution and disk diffusion using Mueller-Hinton media with and without supplementation with 5% blood. By using currently published parameters of the National Committee for Clinical Laboratory Standards for the disk diffusion test, we found that strains for which MICs were 8 to 32 micrograms/ml were incorrectly placed in the susceptible or intermediate category, which caused both very major (1.9%) and minor (11.5%) errors. When we used newer, recently proposed breakpoints for vancomycin, we found 13.5% minor errors but no very major errors. Changing disk diffusion breakpoints to less than or equal to 14 mm for resistant [corrected] and greater than or equal to 15 mm for susceptible [corrected] would eliminate the problem for the strains with MICs of 32 micrograms/ml but not for those with MICs of 8 micrograms/ml. For those strains, it is necessary to perform an MIC test to differentiate them from strains with MICs of less than or equal to 4 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2778080      PMCID: PMC267762          DOI: 10.1128/jcm.27.9.2140-2142.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Two new antibiotics; antibacterial activity of novobiocin and vancomycin.

Authors:  R W FAIRBROTHER; B L WILLIAMS
Journal:  Lancet       Date:  1956-12-08       Impact factor: 79.321

2.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

3.  Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children.

Authors:  M W Kline; E O Mason; S L Kaplan; L B Lamberth; G S Johnson
Journal:  J Antimicrob Chemother       Date:  1987-08       Impact factor: 5.790

4.  Evaluation of teicoplanin and vancomycin disk susceptibility tests.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

5.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

6.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

7.  In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.

Authors:  J H Jorgensen; L A Maher; J S Redding
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

8.  Vancomycin-resistant Streptococcaceae from clinical material.

Authors:  R Lütticken; G Kunstmann
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1988-01

9.  Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis.

Authors:  D C Shanson; M Tadayon
Journal:  J Hosp Infect       Date:  1986-03       Impact factor: 3.926

10.  Recovery of resistant enterococci during vancomycin prophylaxis.

Authors:  A H Kaplan; P H Gilligan; R R Facklam
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

View more
  32 in total

Review 1.  Resistance of enterococci to glycopeptides.

Authors:  P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

2.  In vitro detection of enterococcal vancomycin resistance.

Authors:  D F Sahm; L Olsen
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

3.  Biographical Feature: Clyde Thornsberry, Ph.D.

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

Review 4.  Antimicrobial resistance among enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

5.  Factors influencing the vitek gram-positive susceptibility system's detection of vanB-encoded vancomycin resistance among enterococci.

Authors:  B Jett; L Free; D F Sahm
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

6.  Species identities of enterococci isolated from clinical specimens.

Authors:  K L Ruoff; L de la Maza; M J Murtagh; J D Spargo; M J Ferraro
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

7.  Recovery of vancomycin-resistant gram-positive cocci from children.

Authors:  M Green; R M Wadowsky; K Barbadora
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

8.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

9.  Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci.

Authors:  K G Van Horn; C A Gedris; K M Rodney; J B Mitchell
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

10.  Low-level vancomycin resistance in Clostridium innocuum.

Authors:  F Mory; A Lozniewski; V David; J P Carlier; L Dubreuil; R Leclercq
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.